Previously Untreated Advanced Urothelial Carcinoma: Update From ESMO 2023

from Medical News Podcast · host PeerDirect

Drs. Rosenberg and Morgans share their insights into 2 late‑breaking abstracts presented at ESMO 2023 on the first‑line treatment of metastatic urothelial carcinoma: EV‑302 on the combination of enfortumab vedotin and pembrolizumab and CheckMate 901 on the combination of nivolumab and gemcitabine/cisplatin.

Episode metadata supplied by the publisher feed · Published Mar 8, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Previously Untreated Advanced Urothelial Carcinoma: Update From ESMO 2023

0:00 12:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 12 minutes long.

When was this Medical News Podcast episode published?

This episode was published on March 8, 2024.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!